From the Journals

Teen vaccines: Where we are now, and how can we go further?


 

Adolescents remain undervaccinated for several diseases, and clinicians need to lead the charge to change this reality, according to new clinical reports issued by the American Academy of Pediatrics Committee on Infectious Diseases.

Teens are lagging behind the Healthy People 2020 vaccination goals for the Tdap, quadrivalent meningococcal conjugate (menACWY), and human papillomavirus (HPV) vaccines, lead authors Henry H. Bernstein, DO, and Joseph A. Bocchini Jr., MD, wrote in the Feb. 6 issue of Pediatrics.

Dr. Joseph A. Bocchini Jr.

Dr. Joseph A. Bocchini Jr.

Much of the problem can be attributed to the notorious difficulty of regularly getting teens to visit their medical home. But parental fears about safety of vaccines and cultural, social, and religious philosophies also interfere with vaccine compliance – especially when it comes to the HPV shots, they said (Pediatrics. 2017 Feb 6. doi: 10.1542/peds.2016-4168).

“Although HPV vaccination rates are slowly improving, they continue to lag far behind Tdap and menACWY rates for both boys and girls,” the authors wrote. Only 63% of girls and 50% of boys have gotten at least one HPV vaccine dose; just 42% of girls and 28% of boys finished the entire three-dose series in 2015.

A recent study found that parents declined the HPV vaccine 56% of the time. The three most common reasons were the belief that their child had a low risk of acquiring HPV; fear that the risk of adverse events was too great and belief that the vaccine wasn’t well researched and hasn’t been on the market long enough.

National Cancer Institute
Last fall, in an effort to increase compliance with the series, the CDC’s Advisory Committee on Immunization Practices established a two-vaccine protocol using a 9-valent HPV vaccine for patients aged 9-14 years. “A two-dose HPV vaccine schedule has the potential to improve completion rates and reduces costs,” the authors wrote. The schedule also has been studied in Canada and found to be as effective as the three-dose schedule.

But teens also are falling behind with less controversial vaccines, the report noted. Fewer than half of teens got a flu shot in the 2015-2016 season. Rates for the MenACWY and Tdap are better, but not optimal (81% and 86%, respectively).

Barriers to optimal immunization

The clinical report puts clinicians on the first line of responsibility and makes no apologies for that.

“One of the greatest challenges is health care provider recommendation, which often lacks consistency and urgency,” the authors said. “Many health care providers do not universally recommend vaccines to eligible populations and do not offer concomitant vaccination with indicated vaccines during a single patient encounter.”

In fact, they noted, a recent physician survey found that only about 60% of pediatricians and family doctors strongly recommend the HPV vaccine for 11- and 12-year-old girls. Several parent surveys have determined that lack of provider recommendation is a leading reason for undervaccination among adolescents.

Teen male is shown receiving a vaccination. Joseph Abbott/Thinkstock

Teen male is shown receiving a vaccination.

Mass-targeted misinformation about vaccines continues to exert a negative effect. Providers can, and do, make a difference here by listening, asking open-ended questions about parental concerns, and providing factual information about vaccines’ safety and efficacy.

A companion clinical report, also authored by Dr. Bernstein and Dr. Bocchini, discusses practical ways to confront these barriers (Pediatrics. 2017 Feb 6. doi: 10.1542/peds.2016-4187). It opens with a strong call to physicians to lead the charge in increasing immunization rates.

“Up to 65% of parents have reported not receiving a recommendation … for immunizations. The major reason for nonreceipt [of Tdap and menACWY] was lack of a health care provider recommendation,” they said.

Overcoming parental vaccine hesitancy is a thorny struggle, the authors acknowledge. But they offer some helpful suggestions, including:

Don’t offer immunizations as “optional.” This opens the door to vaccine dismissal. Instead, “strongly endorse all universally recommended vaccines as important for adolescents’ health.”

Ask open-ended questions to get at the root of parental hesitancy. Give fact-based, medically sound information. Stress that doctors are parent partners in raising healthy children and protecting them from disease.

Stress the big-picture benefits of vaccines. Telling parents that the HPV vaccine prevents cancer lifelong is a powerful message. “Up-to-date information on current events and disease outbreaks is a tool to bring into the conversation about vaccines as well.”

Review the vaccine timeline. Do everything possible to ensure parents follow up and complete each series. “Follow-up immunization visits should be scheduled before the family leaves the care setting.”

Don’t give up when a parent refuses a vaccine. “Although it may be challenging, it’s important that health care providers offer the vaccine at the next most appropriate time. Perseverance is critical for vaccine uptake and immunization rates.”

Dr. Bernstein and Dr. Bocchini also suggest that vaccine uptake could be boosted by a mental re-set of the office visit. “Missed opportunities for adolescent immunizations,” such as sick calls, are a prime example. “The majority of vaccines are administered during well-child visit [sports or camp physicals]. … However, acute care visits or sick visits in the patient-centered medical home are also an opportunity to deliver vaccines or to discuss upcoming vaccines,” they said.

Education and communication are essential to improving vaccine uptake, the report concludes. “Appropriate techniques for approaching adolescent patients and their parents in the office to encourage immunizations are important skills for healthcare providers. The key to increasing immunization rates and decreasing vaccine-preventable disease … is to focus on educating adolescents and strengthening health care providers’ recommendations by using all clinical opportunities to assess immunization status and provide needed vaccinations.”

Neither Dr Bernstein nor Dr. Bocchini had any financial disclosures.

Need help talking about teen vaccines? Check out these resources

The American Academy of Pediatrics offered the following resources designed to help clinicians communicate effectively when talking to patients and parents about vaccines:

Talking to parents about the HPV vaccine. This website hosted by the Centers for Disease Control and Prevention includes a link to the latest vaccination recommendations, as well as a tip sheet with HPV vaccine talking points, a fact sheet on the vaccine’s safety data, and a video with four clinical vignettes that model effective communication.

The HPV Champion Toolkit. This contains numerous resources to help clinicians learn to educate other health care professionals, discuss HPV vaccination with parents, and make practice changes to increase HPV vaccine uptake.

You Are the Key to HPV Prevention. This CDC video presents up-to-date information on HPV infection and disease, the HPV vaccine, and ways to successfully communicate with patients and their parents about HPV vaccination.

Adolescentvaccination.org. The National Foundation for Infectious Diseases maintains a website is entirely devoted to adolescent vaccination issues. It contains resources for clinicians, and parents.

Top Strategies for Increasing Vaccine Coverage. This is a report by the American Academy of Pediatrics.

You Call the Shots. This is an interactive, Web-based immunization training course created by the CDC.

Suggestions to Improve Your Immunization Services. This is a checklist of suggestions, by the Immunization Action.

On Twitter @Alz_Gal

Recommended Reading

Dengue vaccine beneficial only in moderate to high transmission settings
MDedge Internal Medicine
Unvaccinated patients rack up billions in preventable costs
MDedge Internal Medicine
2014-2015 influenza vaccine ineffective against predominant strain
MDedge Internal Medicine
Low parental confidence in HPV vaccine stymies adolescent vaccination rates
MDedge Internal Medicine
Another Zika vaccine heads to Phase I trials
MDedge Internal Medicine
The art of persuasion
MDedge Internal Medicine
Historic HIV vaccine efficacy study underway in South Africa
MDedge Internal Medicine
Statin use increases risk of herpes zoster
MDedge Internal Medicine
Model: Quadrivalent vaccine could cost effectively cut MSM’s HPV-related cancers
MDedge Internal Medicine
ACIP releases updated guidance for adult vaccinations
MDedge Internal Medicine